Does the media prefer OPTI or FUM?

In the previous week, OptiBiotix Health and OptiBiotix Health both had 1 articles in the media. OptiBiotix Health's average media sentiment score of 0.67 beat Futura Medical's score of 0.37 indicating that OptiBiotix Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OptiBiotix Health 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Futura Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer FUM or TLM?

In the previous week, Futura Medical and Futura Medical both had 1 articles in the media. Futura Medical's average media sentiment score of 0.37 beat Talisman Metals' score of 0.00 indicating that Futura Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Futura Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Talisman Metals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is TCF or FUM more profitable?

Futura Medical has a net margin of -534.62% compared to Theracryf's net margin of -792.17%. Theracryf's return on equity of -37.30% beat Futura Medical's return on equity. Company Net Margins Return on Equity Return on Assets Theracryf -792.17% -37.30% -48.26% Futura Medical -534.62% -310.00% -26.59%

Is NFX or FUM more profitable?

Nuformix has a net margin of 0.00% compared to Futura Medical's net margin of -534.62%. Nuformix's return on equity of -83.53% beat Futura Medical's return on equity. Company Net Margins Return on Equity Return on Assets Nuformix N/A -83.53% -17.20% Futura Medical -534.62% -310.00% -26.59%

Futura Medical (FUM) Competitors

GBX 0.42 +0.02 (+5.00%)

As of 07/17/2026 12:18 PM Eastern

Compare

FUM vs. BVX, OPTI, TLM, TCF, and NFX

Should you buy Futura Medical stock or one of its competitors? MarketBeat compares Futura Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Futura Medical include BiVictriX Therapeutics (BVX), OptiBiotix Health (OPTI), Talisman Metals (TLM), Theracryf (TCF), and Nuformix (NFX). These companies are all part of the "biotechnology" industry.

How does Futura Medical compare to BiVictriX Therapeutics?

Futura Medical (LON:FUM) and BiVictriX Therapeutics (LON:BVX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, media sentiment, dividends, valuation and earnings.

BiVictriX Therapeutics has a net margin of 0.00% compared to Futura Medical's net margin of -534.62%. BiVictriX Therapeutics' return on equity of -103.99% beat Futura Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Futura Medical	-534.62%	-310.00%	-26.59%
BiVictriX Therapeutics	N/A	-103.99%	-62.99%

1.0% of Futura Medical shares are owned by institutional investors. Comparatively, 30.8% of BiVictriX Therapeutics shares are owned by institutional investors. 16.0% of Futura Medical shares are owned by company insiders. Comparatively, 42.6% of BiVictriX Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

BiVictriX Therapeutics has lower revenue, but higher earnings than Futura Medical. Futura Medical is trading at a lower price-to-earnings ratio than BiVictriX Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Futura Medical	£1.70M	1.44	-£3.88M	-£2.78	N/A
BiVictriX Therapeutics	N/A	N/A	-£2.67M	-£0.04	N/A

In the previous week, Futura Medical had 1 more articles in the media than BiVictriX Therapeutics. MarketBeat recorded 1 mentions for Futura Medical and 0 mentions for BiVictriX Therapeutics. Futura Medical's average media sentiment score of 0.37 beat BiVictriX Therapeutics' score of 0.00 indicating that Futura Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Futura Medical	Neutral
BiVictriX Therapeutics	Neutral

Futura Medical has a beta of 0.021, meaning that its stock price is 98% less volatile than the broader market. Comparatively, BiVictriX Therapeutics has a beta of -0.73, meaning that its stock price is 173% less volatile than the broader market.

Summary

Futura Medical and BiVictriX Therapeutics tied by winning 6 of the 12 factors compared between the two stocks.

How does Futura Medical compare to OptiBiotix Health?

OptiBiotix Health (LON:OPTI) and Futura Medical (LON:FUM) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

0.4% of OptiBiotix Health shares are held by institutional investors. Comparatively, 1.0% of Futura Medical shares are held by institutional investors. 26.8% of OptiBiotix Health shares are held by insiders. Comparatively, 16.0% of Futura Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

OptiBiotix Health has a beta of 1.849, meaning that its stock price is 85% more volatile than the broader market. Comparatively, Futura Medical has a beta of 0.021, meaning that its stock price is 98% less volatile than the broader market.

OptiBiotix Health has a net margin of -333.62% compared to Futura Medical's net margin of -534.62%. OptiBiotix Health's return on equity of -52.92% beat Futura Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OptiBiotix Health	-333.62%	-52.92%	-13.93%
Futura Medical	-534.62%	-310.00%	-26.59%

OptiBiotix Health has higher earnings, but lower revenue than Futura Medical. OptiBiotix Health is trading at a lower price-to-earnings ratio than Futura Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OptiBiotix Health	£1.17M	4.95	-£3.09M	-£3.84	N/A
Futura Medical	£1.70M	1.44	-£3.88M	-£2.78	N/A

In the previous week, OptiBiotix Health and OptiBiotix Health both had 1 articles in the media. OptiBiotix Health's average media sentiment score of 0.67 beat Futura Medical's score of 0.37 indicating that OptiBiotix Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OptiBiotix Health	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Futura Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

OptiBiotix Health beats Futura Medical on 8 of the 12 factors compared between the two stocks.

How does Futura Medical compare to Talisman Metals?

Futura Medical (LON:FUM) and Talisman Metals (LON:TLM) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, earnings, profitability, valuation, dividends and risk.

Talisman Metals has a net margin of 0.00% compared to Futura Medical's net margin of -534.62%. Talisman Metals' return on equity of -32.71% beat Futura Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Futura Medical	-534.62%	-310.00%	-26.59%
Talisman Metals	N/A	-32.71%	3.70%

Talisman Metals has lower revenue, but higher earnings than Futura Medical. Futura Medical is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Futura Medical	£1.70M	1.44	-£3.88M	-£2.78	N/A
Talisman Metals	N/A	N/A	-£1.35M	£12.39	0.52

1.0% of Futura Medical shares are owned by institutional investors. Comparatively, 1.4% of Talisman Metals shares are owned by institutional investors. 16.0% of Futura Medical shares are owned by insiders. Comparatively, 95.2% of Talisman Metals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Futura Medical and Futura Medical both had 1 articles in the media. Futura Medical's average media sentiment score of 0.37 beat Talisman Metals' score of 0.00 indicating that Futura Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Futura Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Talisman Metals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Futura Medical has a beta of 0.021, meaning that its stock price is 98% less volatile than the broader market. Comparatively, Talisman Metals has a beta of 0.9, meaning that its stock price is 10% less volatile than the broader market.

Summary

Talisman Metals beats Futura Medical on 9 of the 11 factors compared between the two stocks.

How does Futura Medical compare to Theracryf?

Theracryf (LON:TCF) and Futura Medical (LON:FUM) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and media sentiment.

Futura Medical has a net margin of -534.62% compared to Theracryf's net margin of -792.17%. Theracryf's return on equity of -37.30% beat Futura Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Theracryf	-792.17%	-37.30%	-48.26%
Futura Medical	-534.62%	-310.00%	-26.59%

Futura Medical has higher revenue and earnings than Theracryf. Theracryf is trading at a lower price-to-earnings ratio than Futura Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Theracryf	N/A	N/A	-£5.45M	-£0.13	N/A
Futura Medical	£1.70M	1.44	-£3.88M	-£2.78	N/A

2.2% of Theracryf shares are held by institutional investors. Comparatively, 1.0% of Futura Medical shares are held by institutional investors. 23.1% of Theracryf shares are held by insiders. Comparatively, 16.0% of Futura Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Futura Medical had 1 more articles in the media than Theracryf. MarketBeat recorded 1 mentions for Futura Medical and 0 mentions for Theracryf. Futura Medical's average media sentiment score of 0.37 beat Theracryf's score of 0.00 indicating that Futura Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Theracryf	Neutral
Futura Medical	Neutral

Theracryf has a beta of 1.406, meaning that its share price is 41% more volatile than the broader market. Comparatively, Futura Medical has a beta of 0.021, meaning that its share price is 98% less volatile than the broader market.

Summary

Futura Medical beats Theracryf on 7 of the 12 factors compared between the two stocks.

How does Futura Medical compare to Nuformix?

Nuformix (LON:NFX) and Futura Medical (LON:FUM) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, earnings, dividends, profitability, valuation and risk.

In the previous week, Futura Medical had 1 more articles in the media than Nuformix. MarketBeat recorded 1 mentions for Futura Medical and 0 mentions for Nuformix. Futura Medical's average media sentiment score of 0.37 beat Nuformix's score of 0.00 indicating that Futura Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Nuformix	Neutral
Futura Medical	Neutral

Nuformix has higher earnings, but lower revenue than Futura Medical. Nuformix is trading at a lower price-to-earnings ratio than Futura Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nuformix	N/A	N/A	-£383.40K	-£0.03	N/A
Futura Medical	£1.70M	1.44	-£3.88M	-£2.78	N/A

0.1% of Nuformix shares are owned by institutional investors. Comparatively, 1.0% of Futura Medical shares are owned by institutional investors. 7.5% of Nuformix shares are owned by insiders. Comparatively, 16.0% of Futura Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Nuformix has a net margin of 0.00% compared to Futura Medical's net margin of -534.62%. Nuformix's return on equity of -83.53% beat Futura Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nuformix	N/A	-83.53%	-17.20%
Futura Medical	-534.62%	-310.00%	-26.59%

Nuformix has a beta of 1.537, meaning that its share price is 54% more volatile than the broader market. Comparatively, Futura Medical has a beta of 0.021, meaning that its share price is 98% less volatile than the broader market.

Summary

Nuformix and Futura Medical tied by winning 6 of the 12 factors compared between the two stocks.

Get Futura Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FUM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FUM vs. The Competition

Export

Metric	Futura Medical	Biotechnology Industry	Medical Sector	LON Exchange
Market Cap	£2.44M	£508.91M	£6.87B	£2.78B
Dividend Yield	4.55%	3.90%	2.67%	6.15%
P/E Ratio	-0.15	3.15	27.26	368.19
Price / Sales	1.44	6,483.71	528.10	84,555.32
Price / Cash	20.43	13.13	51.46	27.89
Price / Book	0.16	87.30	10.69	7.53
Net Income	-£3.88M	-£96.07M	£3.59B	£5.89B
7 Day Performance	13.51%	-2.14%	-2.20%	5.78%
1 Month Performance	-22.22%	1.13%	1.63%	4.65%
1 Year Performance	-96.18%	56.86%	25.59%	61.87%

Futura Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FUM Futura Medical	N/A	GBX 0.42 +5.0%	N/A	-96.1%	£2.44M	£1.70M	N/A	12	Gap Up High Trading Volume
BVX BiVictriX Therapeutics	N/A	N/A	N/A	N/A	£8.25M	N/A	N/A	17	Gap Up High Trading Volume
OPTI OptiBiotix Health	N/A	GBX 6.30 -1.6%	N/A	-49.2%	£6.51M	£1.17M	N/A	1
TLM Talisman Metals	N/A	GBX 7.50 +3.4%	N/A	N/A	£4.81M	N/A	0.61	5	Gap Up
TCF Theracryf	N/A	GBX 0.22 +0.9%	N/A	-20.2%	£4.66M	N/A	N/A	10	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:FUM) was last updated on 7/18/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Futura Medical (FUM) Competitors

FUM vs. BVX, OPTI, TLM, TCF, and NFX

How does Futura Medical compare to BiVictriX Therapeutics?

Summary

How does Futura Medical compare to OptiBiotix Health?

Summary

How does Futura Medical compare to Talisman Metals?

Summary

How does Futura Medical compare to Theracryf?

Summary

How does Futura Medical compare to Nuformix?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FUM vs. The Competition

Futura Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Futura Medical (FUM) Competitors

FUM vs. BVX, OPTI, TLM, TCF, and NFX

How does Futura Medical compare to BiVictriX Therapeutics?

Is FUM or BVX more profitable?

Do institutionals & insiders believe in FUM or BVX?

Which has stronger valuation and earnings, FUM or BVX?

Does the media prefer FUM or BVX?

Which has more volatility and risk, FUM or BVX?

Summary

How does Futura Medical compare to OptiBiotix Health?

Do insiders & institutionals believe in OPTI or FUM?

Which has more volatility & risk, OPTI or FUM?

Is OPTI or FUM more profitable?

Which has higher earnings & valuation, OPTI or FUM?

Does the media prefer OPTI or FUM?

Summary

How does Futura Medical compare to Talisman Metals?

Is FUM or TLM more profitable?

Which has higher valuation and earnings, FUM or TLM?

Do institutionals & insiders hold more shares of FUM or TLM?

Does the media prefer FUM or TLM?

Which has more volatility and risk, FUM or TLM?

Summary

How does Futura Medical compare to Theracryf?

Is TCF or FUM more profitable?

Which has higher valuation & earnings, TCF or FUM?

Do insiders & institutionals have more ownership in TCF or FUM?

Does the media favor TCF or FUM?

Which has more volatility & risk, TCF or FUM?

Summary

How does Futura Medical compare to Nuformix?

Does the media favor NFX or FUM?

Which has better earnings & valuation, NFX or FUM?

Do institutionals and insiders believe in NFX or FUM?

Is NFX or FUM more profitable?

Which has more risk and volatility, NFX or FUM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FUM vs. The Competition

Futura Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools